Gara Jalqabaatti › Baayyee Ulfaataa › California › Concord
Qorannoo klinikaalii Baayyee Ulfaataa Concord, CA keessatti
Qorannoo 16 Baayyee Ulfaataa f Concord fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Walnut Creek · Miili 5 fagaatti
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Walnut Creek · Miili 5 fagaatti
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- John Muir Health - Concord /ID# 282469, Concord
- Diablo Clinical Research /ID# 282530, Walnut Creek · Miili 5 fagaatti
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- Diablo Clinical Research - Flourish Research, Walnut Creek · Miili 5 fagaatti
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Walnut Creek · Miili 5 fagaatti
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Walnut Creek · Miili 5 fagaatti
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Namoota walitti qabaa jiraSadarkaa 1
- Diablo Clinical Research, Inc., Walnut Creek · Miili 5 fagaatti
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
Qorannoo biroo Concord keessatti
- ObesityQorannoo 18
- Kansara Qara'a Non-Small CellQorannoo 14
- Dhibee Gaddii GuddaaQorannoo 12
- Sukkaraa Gosa 2Qorannoo 10
- Saree OljooQorannoo 9
- Dhibee QaraQorannoo 9
- MigreeniiQorannoo 8
- Saree (Gosoota Hunda)Qorannoo 7
- DepreshiniiQorannoo 6
- Kansarii ProstateQorannoo 6
- DaayabeetisiisQorannoo 5
- Dhukkubaa AlzheimerQorannoo 5
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.